doc. RNDr. Jakub Neradil, Ph.D.
Associate professor, Section of Genetics and Molecular Biology
office: bldg. C13/316
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 6003 |
---|---|
e‑mail: | jneradil@sci.muni.cz |
social and academic networks: |
---|
Total number of publications: 80
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
-
NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation
Cells, year: 2020, volume: 9, edition: 3, DOI
-
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
Cancers, year: 2020, volume: 12, edition: 12, DOI
-
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
International Journal of Molecular Sciences, year: 2020, volume: 21, edition: 9, DOI
-
Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells
Cancers, year: 2020, volume: 12, edition: 1, DOI
2019
-
Epidermal growth factor receptor as a new target in the treatment of giant cell tumor of bone
Year: 2019, type: Conference abstract
-
Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
Frontiers in Oncology, year: 2019, volume: 9, edition: JUL 17 2019, DOI
-
Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
Frontiers in Oncology, year: 2019, volume: 9, edition: SEP 20, DOI
2018
-
Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
International Journal of Molecular Sciences, year: 2018, volume: 19, edition: 9, DOI
-
Letter to Editor: FS Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)
Bone, year: 2018, volume: 116, edition: NOV, DOI